Topical products, widely used to manage skin conditions, have evolved from simple potions
to sophisticated delivery systems. Their development has been facilitated by advances in …

The limitations of conventional therapeutic drugs necessitate the importance of developing
novel therapeutics to treat diverse diseases. Conventional drugs have poor blood circulation …

In this article, we review findings from basic, experimental research on children that suggest
that the liking of sweet and the dislike of bitter tastes reflect children's basic biology. Children …

Abstract BitterDB (http://bitterdb. agri. huji. ac. il) was introduced in 2012 as a central
resource for information on bitter-tasting molecules and their receptors. The information in …

Selecting the appropriate formulation and solubility-enabling technology for poorly water
soluble drugs is an essential element in the development of formulations for paediatric …

Paediatric formulation design is complex as there is a need to understand the
developmental physiological changes that occur during childhood and their impact on the …

6. INTERVENTIONS TO ADDRESS CHILDHOOD OBESITY 6.1. Preconception and
pregnancy: reducing obesity risk 6.2. Obesity prevention in infants, preschool children …

Rationale Consideration by the US Drug Enforcement Administration and Food and Drug
Administration of placing kratom into Schedule I of the Controlled Substances Act (CSA) …

The total number of paediatric formulations available only account for a small proportion of
the full therapeutic plethora required to effectively treat paediatrics and, therefore, the …

Bitter taste is an innately aversive taste modality that is considered to protect animals from
consuming toxic compounds. Yet, bitterness is not always noxious and some bitter …